Dinesh Patel

Dinesh Patel

Chief Executive Officer at PROTAGONIST THERAPEUTICS, INC.

Net worth: 52 M $ as of 31/05/2026

69 year
Health Technology
Consumer Services
Commercial Services

Profile

Dinesh V.
Patel
was the founder of Miikana Therapeutics, Inc., founded in 2003, where the title held was President & Chief Executive Officer from 2003 to 2005.
Current jobs include President, Chief Executive Officer & Director at Protagonist Pty Ltd. since 2013, President, Chief Executive Officer & Director at Protagonist Therapeutics, Inc. since 2019, and Independent Director at Sai Life Sciences Ltd. starting in 2025.
Former jobs include President & Chief Executive Officer at Arête Therapeutics, Inc. from 2006 to 2008, Chemistry Director at Affymax, Inc. from 1993 to 1996, Medicinal Chemist at Bristol Myers Squibb Co. from 1985 to 1993, and Senior Vice President-Licensing & Drug Discovery at Vicuron Pharmaceuticals LLC from 1996 to 2003.
Education includes a doctorate from Rutgers State University of New Jersey and an undergraduate degree from Sardar Patel University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/05/2026 523,478 ( 0.81% ) 52 M $ 31/05/2026

Dinesh Patel active positions

CompaniesPositionStart
PROTAGONIST THERAPEUTICS, INC. Chief Executive Officer 01/12/2008
SAI LIFE SCIENCES LIMITED Director/Board Member 24/03/2025
Chief Executive Officer 06/07/2009

Former positions of Dinesh Patel

CompaniesPositionEnd
Chief Executive Officer 01/01/2008
Chief Executive Officer 01/01/2005
Corporate Officer/Principal 01/01/2003
AFFYMAX, INC. Corporate Officer/Principal 01/01/1996
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/01/1993
See the detail of Dinesh Patel's experience

Training of Dinesh Patel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!